Ignatov A - Search Results

1

G-protein-coupled estrogen receptor GPR30 and tamoxifen resistance in breast cancer.

Ignatov A, Ignatov T, Weissenborn C, Eggemann H, Bischoff J, Semczuk A, Roessner A, Costa SD, Kalinski T. Ignatov A, et al. Among authors: ignatov t. Breast Cancer Res Treat. 2011 Jul;128(2):457-66. doi: 10.1007/s10549-011-1584-1. Epub 2011 May 24. Breast Cancer Res Treat. 2011. PMID: 21607586

2

An 11-year retrospective study of totally implanted central venous access ports: complications and patient satisfaction.

Ignatov A, Hoffman O, Smith B, Fahlke J, Peters B, Bischoff J, Costa SD. Ignatov A, et al. Eur J Surg Oncol. 2009 Mar;35(3):241-6. doi: 10.1016/j.ejso.2008.01.020. Epub 2008 Mar 10. Eur J Surg Oncol. 2009. PMID: 18329836

3

Acute hepatic failure following monotherapy with sunitinib for ovarian cancer.

Taran A, Ignatov A, Smith B, Costa SD, Bischoff J. Taran A, et al. Among authors: ignatov a. Cancer Chemother Pharmacol. 2009 Apr;63(5):971-2. doi: 10.1007/s00280-008-0814-7. Epub 2008 Aug 21. Cancer Chemother Pharmacol. 2009. PMID: 18716778 No abstract available.

4

P16 alterations increase the metastatic potential of endometrial carcinoma.

Ignatov A, Bischoff J, Schwarzenau C, Krebs T, Kuester D, Herrmann K, Costa SD, Roessner A, Semczuk A, Schneider-Stock R. Ignatov A, et al. Gynecol Oncol. 2008 Nov;111(2):365-71. doi: 10.1016/j.ygyno.2008.07.037. Epub 2008 Sep 14. Gynecol Oncol. 2008. PMID: 18790522

5

Methotrexate monotherapy for high-risk gestational trophoblastic neoplasia after therapy with etoposide, methotrexate, and dactinomycin: a case report.

Taran A, Ignatov A, Smith B, Bischoff J, Costa SD. Taran A, et al. Among authors: ignatov a. Am J Obstet Gynecol. 2008 Nov;199(5):e6-8. doi: 10.1016/j.ajog.2008.07.045. Am J Obstet Gynecol. 2008. PMID: 18984073

6

APC promoter hypermethylation is an early event in endometrial tumorigenesis.

Ignatov A, Bischoff J, Ignatov T, Schwarzenau C, Krebs T, Kuester D, Costa SD, Roessner A, Semczuk A, Schneider-Stock R. Ignatov A, et al. Among authors: ignatov t. Cancer Sci. 2010 Feb;101(2):321-7. doi: 10.1111/j.1349-7006.2009.01397.x. Epub 2009 Oct 12. Cancer Sci. 2010. PMID: 19900189 Free PMC article.

7

Role of GPR30 in the mechanisms of tamoxifen resistance in breast cancer MCF-7 cells.

Ignatov A, Ignatov T, Roessner A, Costa SD, Kalinski T. Ignatov A, et al. Among authors: ignatov t. Breast Cancer Res Treat. 2010 Aug;123(1):87-96. doi: 10.1007/s10549-009-0624-6. Epub 2009 Nov 13. Breast Cancer Res Treat. 2010. PMID: 19911269

8

Interval between port catheter flushing can be extended to four months.

Ignatov A, Ignatov T, Taran A, Smith B, Costa SD, Bischoff J. Ignatov A, et al. Among authors: ignatov t. Gynecol Obstet Invest. 2010;70(2):91-4. doi: 10.1159/000294919. Epub 2010 Mar 11. Gynecol Obstet Invest. 2010. PMID: 20224280

9

The pattern of p14ARF expression in primary and metastatic human endometrial carcinomas: correlation with clinicopathological features and TP53 pathway alterations.

Olcha P, Cybulski M, Skomra D, Obrzut B, Ignatov A, Jóźwik M, Schneider-Stock R, Semczuk A. Olcha P, et al. Among authors: ignatov a. Int J Gynecol Cancer. 2010 Aug;20(6):993-9. doi: 10.1111/IGC.0b013e3181e76a4d. Int J Gynecol Cancer. 2010. PMID: 20683407

10

The Role of Targeted Agents in the Treatment of Metastatic Breast Cancer.

Bischoff J, Ignatov A. Bischoff J, et al. Among authors: ignatov a. Breast Care (Basel). 2010;5(3):134-141. doi: 10.1159/000314996. Epub 2010 Jun 16. Breast Care (Basel). 2010. PMID: 20847826 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

239 results

Search Page

Filters